| Literature DB >> 24130250 |
Joshua D Maier1, Steven N Levine2.
Abstract
Hypercalcemia may be seen in a variety of clinical settings and often requires intensive management when serum calcium levels are dramatically elevated. All of the many etiologies of mild hypercalcemia can lead to severe hypercalcemia. Knowledge of the physiologic mechanisms involved in maintaining normocalcemia and basic pathophysiology is essential for making a timely diagnosis and hence prompt institution of etiology-specific therapy. The development of new medications and critical reviews of traditional therapies have changed the treatment paradigm for severe hypercalcemia, calling for a more limited role for aggressive isotonic fluid administration and furosemide and an expanded role for calcitonin and the bisphosphonates. Experimental therapies such as denosumab show promise.Entities:
Keywords: hypercalcemia; hyperparathyroidism; malignancy-associated hypercalcemia; parathyroid hormone–related protein
Mesh:
Substances:
Year: 2013 PMID: 24130250 DOI: 10.1177/0885066613507530
Source DB: PubMed Journal: J Intensive Care Med ISSN: 0885-0666 Impact factor: 3.510